Dr. Jill Biden, National Minority Quality Forum, Global Sponsors & CROs Discuss the Future of Healthcare & Clinical Research ...
October 23 2018 - 8:30AM
Business Wire
Over 1,000 industry leaders to discuss best
practices and the hottest topics in the digital transformation of
life sciences
News Summary
- The two-day program features keynotes
from global sponsors and CROs and over 50 breakout sessions
- Over 1,000 attendees to share best
practices and connect with fellow life science industry
leaders
- Conference breakouts offer attendees
interactive, hands-on learning opportunities to design, conduct,
manage, and monitor the next generation of clinical research
studies
Medidata NEXT NYC, the premier conference on the digital
transformation of life sciences, will feature keynotes from global
sponsors and CROs, and Medidata (NASDAQ: MDSO). The customer
conference runs from October 24-25 at Spring Studios in New York
City.
Medidata NEXT NYC is the centerpiece of the global conference
series Medidata NEXT, an industry nexus where science meets
technology meets the future. The event’s keynotes include
visionaries who are at the leading edge of healthcare industry
innovation:
- Dr. Jill Biden, educator and
former Second Lady of the United States (2009-2017)
- Jeff Allen, Ph.D., president and CEO
of Friends of Cancer Research
- Gary A. Puckrein, president and CEO
of the National Minority Quality Forum
Thought-provoking breakout sessions will highlight cutting-edge
innovation within each phase of the clinical development lifecycle,
including study planning and execution, trial management, data
analytics, patient engagement, and risk-based monitoring. Medidata
customers and partners will lead over 80% of these sessions,
featuring senior executives and experts from global sponsors and
CROs.
To inspire innovation around greater diversity in clinical
trials, Medidata NEXT NYC will also host a two-day hackathon:
Closing the Diversity Gap in Clinical Trials. The hackathon will
inspire innovators to create novel mobile applications with the
Medidata AppConnect software kit to increase diversity and
inclusion in clinical trials.
“Hearing stories of innovation and success from more than 1,000
life science leaders is a great source of inspiration and pride,”
said Glen de Vries, president and co-founder, Medidata. “NEXT NYC
is a reflection of our company’s true partnership with sponsors and
CROs who are improving patient lives around the world.”
About Medidata NEXT:
The largest annual event series of its kind, Medidata NEXT
attracts over 3,000 leaders in drug and device development,
clinical operations, data management, biostatistics, and digital
medicine innovation industries for networking and learning across
seven gatherings in Basel, Frankfurt, London, New York, Seoul,
Shanghai and Tokyo.
About Medidata
Medidata is leading the digital transformation of life sciences,
with the world's most used platform for clinical development,
commercial, and real-world data. Powered by artificial intelligence
and delivered by the #1 ranked industry experts, the Intelligent
Platform for Life Sciences helps pharmaceutical, biotech, medical
device companies, and academic researchers accelerate value,
minimize risk and optimize outcomes. Medidata serves more than
1,000 customers and partners worldwide and empowers more than
100,000 certified users everyday to create hope for millions of
patients. Discover the future of life sciences: www.mdsol.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181023005667/en/
Medidata Solutions:Investors:Betsy Frank,
917-522-4620bfrank@mdsol.comorMedia:Erik Snider,
646-362-2997esnider@mdsol.com
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Apr 2023 to Apr 2024